Ikarian Capital, LLC Capricor Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 400,000 shares of CAPR stock, worth $4.1 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
400,000
Previous 300,000
33.33%
Holding current value
$4.1 Million
Previous $4.16 Million
8.64%
% of portfolio
0.53%
Previous 0.69%
Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
17.2MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$23.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$23.1 Million0.12% of portfolio
-
State Street Corp Boston, MA1.84MShares$18.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$16.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$9.24 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $250M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...